Immunomodulation With Romiplostim in Young Adults With ITP

NCT02760251 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Immune Thrombocytopenia

Interventions

DRUG: romiplostim

Sponsor

University Hospital, Basel, Switzerland

Collaborators

[object Object]